1. The Role of Inflammasome in Cancers and Potential Therapeutic Targets
   Pooya Farhangnia et al, 2023, Handbook of Cancer and Immunology CrossRef
2. Targeting the NLRP3 Inflammasome as a New Therapeutic Option for Overcoming Cancer
   Sonia Missiroli et al, 2021, Cancers CrossRef
3. Inflammasomes—New Contributors to Blood Diseases
   Jaromir Tomasik et al, 2022, International Journal of Molecular Sciences CrossRef
4. Insights Regarding the Role of Inflammasomes in Leukemia: What Do We Know?
   Fabíola Silva Alves-Hanna et al, 2023, Journal of Immunology Research CrossRef
5. AHR signaling pathway mediates mitochondrial oxidative phosphorylation which leads to cytarabine resistance
   Yan Jia et al, 2024, Acta Biochimica et Biophysica Sinica CrossRef
6. The NLRP3 Inflammasome and Its Role in the Pathogenicity of Leukemia
   Laura Urwanisch et al, 2021, International Journal of Molecular Sciences CrossRef
7. Does NLRP3 Inflammasome and Aryl Hydrocarbon Receptor Play an Interlinked Role in Bowel Inflammation and Colitis-Associated Colorectal Cancer?
   Ivan Qi Han Ngui et al, 2020, Molecules CrossRef
8. NLRP3 Inflammasome Promotes the Progression of Acute Myeloid Leukemia via IL-1β Pathway
   Chaoqin Zhong et al, 2021, Frontiers in Immunology CrossRef
9. Environmental pollutant N‐N′ethylnitrosourea‐induced leukemic NLRP3 inflammasome activation and its amelioration by Eclipta prostrata and its active compound wedelolactone
   Subhashree Bhattacharyya et al, 2022, Environmental Toxicology CrossRef
10. Microenvironmental Features Driving Immune Evasion in Myelodysplastic Syndromes and Acute Myeloid Leukemia
    Georgios Petros Barakos et al, 2022, Diseases CrossRef